Home » Topics » BioWorld Science

BioWorld Science
RSS

Cassava Sciences announces phase IIa data for PTI-125 in Alzheimer's disease

Sep. 10, 2019

Results from phase II ADAMANT trial of AADvac-1 in Alzheimer's disease reported

Sep. 10, 2019

Lilly reports promising results from phase I/II study of selpercatinib in RET fusion-positive NSCLC

Sep. 10, 2019

Aptorum announces updates in preclinical pipeline

Sep. 10, 2019

Phospholipase D inhibitors developed for testing in neurodegeneration models

Sep. 10, 2019

Experimental model developed for PACAP-induced headache

Sep. 10, 2019

Cheerful gut bug has relationship with antidepressant

Sep. 10, 2019

Parasite protects T cells from HIV

Sep. 10, 2019

Nicotinamide riboside shows promise for myocardial infarction

Sep. 10, 2019

Passage Bio licenses gene therapy program for CMT2A from Penn

Sep. 9, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026